Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Cerchietti Research Lab
Explore this Website
Home
Research
Toggle Research menu options
Projects
Lab Team
Publications
News
Weill Cornell Medicine
Care
Discover
Teach
Home
Research
Lab Team
Publications
News
Home
Publications
Publications
Found 14 results
Author
Title
Type
Year
Filters:
Author
is
Shaknovich, Rita
[Clear All Filters]
2016
Cardenas MG
,
Yu W
,
Beguelin W
,
Teater MR
,
Geng H
,
Goldstein RL
,
Oswald E
,
Hatzi K
,
Yang S-N
,
Cohen J
et al.
. 2016.
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.
.
J Clin Invest.
2015
Pan H
,
Jiang Y
,
Boi M
,
Tabbò F
,
Redmond D
,
Nie K
,
Ladetto M
,
Chiappella A
,
Cerchietti L
,
Shaknovich R
et al.
. 2015.
Epigenomic evolution in diffuse large B-cell lymphomas.
.
Nat Commun. 6:6921.
Goldstein RL
,
Yang SNing
,
Taldone T
,
Chang B
,
Gerecitano J
,
Elenitoba-Johnson K
,
Shaknovich R
,
Tam W
,
Leonard JP
,
Chiosis G
et al.
. 2015.
Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma.
.
J Clin Invest. 125(12):4559-71.
2013
De S
,
Shaknovich R
,
Riester M
,
Elemento O
,
Geng H
,
Kormaksson M
,
Jiang Y
,
Woolcock B
,
Johnson N
,
Polo JM
et al.
. 2013.
Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity.
.
PLoS Genet. 9(1):e1003137.
Beguelin W
,
Popovic R
,
Teater M
,
Jiang Y
,
Bunting KL
,
Rosen M
,
Shen H
,
Yang SNing
,
Wang L
,
Ezponda T
et al.
. 2013.
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.
.
Cancer Cell. 23(5):677-92.
Clozel T
,
Yang SN
,
Elstrom RL
,
Tam W
,
Martin P
,
Kormaksson M
,
Banerjee S
,
Vasanthakumar A
,
Culjkovic B
,
Scott DW
et al.
. 2013.
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.
.
Cancer Discov. 3(9):1002-19.
2012
Fontan L
,
Yang C
,
Kabaleeswaran V
,
Volpon L
,
Osborne MJ
,
Beltran E
,
Garcia M
,
Cerchietti L
,
Shaknovich R
,
Yang SNing
et al.
. 2012.
MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo.
.
Cancer Cell. 22(6):812-24.
2011
Shaknovich R
,
Cerchietti L
,
Tsikitas L
,
Kormaksson M
,
De S
,
Figueroa ME
,
Ballon G
,
Yang SNing
,
Weinhold N
,
Reimers M
et al.
. 2011.
DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation.
.
Blood. 118(13):3559-69.
2010
Cerchietti LC
,
Hatzi K
,
Caldas-Lopes E
,
Yang SNing
,
Figueroa ME
,
Morin RD
,
Hirst M
,
Mendez L
,
Shaknovich R
,
Cole PA
et al.
. 2010.
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.
.
J Clin Invest. 120(12):4569-82.
Shaknovich R
,
Geng H
,
Johnson NA
,
Tsikitas L
,
Cerchietti L
,
Greally JM
,
Gascoyne RD
,
Elemento O
,
Melnick A
. 2010.
DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma.
.
Blood. 116(20):e81-9.
2009
Ci W
,
Polo JM
,
Cerchietti L
,
Shaknovich R
,
Wang L
,
Yang SNing
,
Ye K
,
Farinha P
,
Horsman DE
,
Gascoyne RD
et al.
. 2009.
The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL.
.
Blood. 113(22):5536-48.
Cerchietti LC
,
Yang SNing
,
Shaknovich R
,
Hatzi K
,
Polo JM
,
Chadburn A
,
Dowdy SF
,
Melnick A
. 2009.
A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo.
.
Blood. 113(15):3397-405.
Cerchietti LC
,
Lopes EC
,
Yang SNing
,
Hatzi K
,
Bunting KL
,
Tsikitas LA
,
Mallik A
,
Robles AI
,
Walling J
,
Varticovski L
et al.
. 2009.
A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas.
.
Nat Med. 15(12):1369-76.
2008
Cerchietti LC
,
Polo JM
,
Da Silva GF
,
Farinha P
,
Shaknovich R
,
Gascoyne RD
,
Dowdy SF
,
Melnick A
. 2008.
Sequential transcription factor targeting for diffuse large B-cell lymphomas.
.
Cancer Res. 68(9):3361-9.